LifeStance Health Group upgraded by UBS with a new price target
$LFST
Medical/Nursing Services
Health Care
UBS upgraded LifeStance Health Group from Neutral to Buy and set a new price target of $8.50
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/27/2025 | $8.50 | Neutral → Buy | UBS |
| 4/8/2025 | $9.00 | Overweight | KeyBanc Capital Markets |
| 4/3/2025 | $8.00 | Buy | Canaccord Genuity |
| 12/16/2024 | $10.00 | Neutral → Buy | Goldman |
| 1/3/2024 | $7.00 | Underweight | Barclays |
| 5/15/2023 | $8.00 → $9.00 | Outperform → Market Perform | TD Cowen |
| 1/6/2023 | $8.00 | Equal-Weight → Overweight | Morgan Stanley |
| 11/7/2022 | $7.25 | Buy | Jefferies |